To evaluate the effectiveness of our pilots with supporting desired SI use, self-efficacy to SI, and women’s contraceptive decision making, among other key outcomes, we are currently conducting mix methods evaluation of our pilot programs in Kenya, Malawi, and Uganda. Results are anticipated in 2024.
In Nigeria, our team conducted a robust evaluation of existing client-centered delivery of self-injection being implemented in public and private retail sectors of Enugu, Lagos and Plateau States. In these three States, we conducted two rounds of each data collection activity:
- Mystery client interactions
- Provider and user IDIs
- Client exit interviews (baseline + 2 rounds of follow-up)
Results from first round of data collection are featured in our ICAN Nigeria brief pictured below.
